Clinical Trials Browser

Phase 2 × INDUSTRY × sipuleucel-T × Clear all

NCT06134232 2025-08-27

ProvONE

Phase 2 Recruiting

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

NCT01487863 2019-03-19

Concurrent vs. Sequential Sipuleucel-T & Abiraterone Treatment in Men With Metastatic Castrate Resistant Prostate Cancer

Phase 2 Completed

69 enrolled 14 charts

Prostatic Neoplasms

NCT01981122 2018-10-24

A Study of Sipuleucel-T With Administration of Enzalutamide in Men With Metastatic Castrate-Resistant Prostate Cancer

Phase 2 Completed

52 enrolled 17 charts

Prostatic Neoplasms

NCT01338012 2017-06-05

mCRPC

Phase 2 Terminated

8 enrolled 10 charts

Prostatic Neoplasms

NCT01431391 2017-05-30

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Phase 2 Completed

68 enrolled 11 charts

Adenocarcinoma, Carcinoma, Genital Neoplasms, Male, Neoplasms, Neoplasms, Glandular and Epithelial, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT00715078 2017-05-23

To Evaluate Sipuleucel-T Manufactured With Different Concentrations of (PA2024) Antigen

Phase 2 Completed

122 enrolled 14 charts

Prostatic Neoplasms

NCT01477749 2015-12-09

Sipuleucel-T Manufacturing Demonstration Study

Phase 2 Completed

47 enrolled 10 charts

Prostatic Neoplasms

NCT00715104 2015-05-04

NeoACT

Phase 2 Completed

42 enrolled 18 charts

Prostatic Neoplasms